InvestorsHub Logo
Followers 31
Posts 2649
Boards Moderated 0
Alias Born 10/28/2013

Re: boi568 post# 293519

Wednesday, 01/20/2021 2:09:54 PM

Wednesday, January 20, 2021 2:09:54 PM

Post# of 462450
$6.7B = 1/3 of market's defacto valuation of Biogen's Aducanumab.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News